Article
Assessment of folate receptor-α and epidermal growth factor receptor expression in pemetrexed-treated non-small-cell lung cancer patients.
Clinical lung cancer - 1 Sept 2014
Christoph Daniel C, Reyna-Asuncion Bernadette, Hassan Biftu, Tran Cindy, Maltzman Julia D, O'Shannessy Daniel J, Gauler Thomas C, Wohlschlaeger Jeremias, Schuler Martin, Eberhardt Wilfried E, Hirsch Fred R
Abstract excerpt
INTRODUCTION: Folate receptor-α regulates cellular uptake of folates and antifolates (eg, pemetrexed) and is frequently expressed in pulmonary adenocarcinoma. EGFR is an established therapeutic target in NSCLC. Therapies targeting FRA or EGFR are available. The association between FRA and EGFR expression in advanced NSCLC has not been explored. Combining therapeutic FRA antibodies with an EGFR inhibitor might be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
